LOADING
Comparing Merck & Company (MRK) and Qualcomm Inc (QCOM) across the Health Care and Technology sectors. This side-by-side analysis covers price, valuation multiples, profitability, growth, dividends, and risk metrics to help investors evaluate these two stocks.
| Metric | MRK | QCOM |
|---|---|---|
| Price | -- | -- |
| Change Today | +0.00% | +0.00% |
| Market Cap | $305.1B | $199.4B |
| P/E Ratio | 34.8 | 20.3 |
| Forward P/E | 24.4 | 16.8 |
| PEG Ratio | 6.10 | 0.60 |
| EPS | $3.55 | $9.31 |
| Revenue Growth (YoY) | 4.9% | -3.5% |
| Profit Margin | 13.6% | 22.3% |
| Return on Equity | 18.9% | 36.1% |
| Dividend Yield | 2.62% | 1.86% |
| Beta | 0.20 | 1.64 |
| 52-Week High | $130.29 | $258.96 |
| 52-Week Low | $74.18 | $121.54 |
| Volume | -- | -- |
Merck & Company is the larger company by market capitalization. Qualcomm Inc trades at a lower P/E ratio, suggesting it may offer better value relative to earnings. Merck & Company offers a higher dividend yield for income investors. Qualcomm Inc has stronger profit margins. Both stocks should be evaluated in the context of your investment goals, risk tolerance, and portfolio diversification needs.